Theranostics and precision medicine special feature.
作者信息
Navalkissoor Shaunak, Gnanasegaran Gopinath, Baum Richard
机构信息
1 Royal Free London NHS Foundation Trust , London , UK.
2 Zentralklinik Bad Berka , Bad Berka , Germany.
出版信息
Br J Radiol. 2018 Nov;91(1091):20189004. doi: 10.1259/bjr.20189004.
Abstract
摘要
相似文献
1
Theranostics and precision medicine special feature.
Br J Radiol. 2018 Nov;91(1091):20189004. doi: 10.1259/bjr.20189004.
2
Ultrasound-based nanomedicine for molecular imaging of prostate cancer: from diagnostics to theranostics.
Nanomedicine (Lond). 2021 Oct;16(23):2029-2032. doi: 10.2217/nnm-2021-0170. Epub 2021 Sep 14.
3
Commentary: Theranostics for stroke: Precision medicine is about tailoring therapy to the mechanism of ischemia.
Neurol India. 2018 Mar-Apr;66(2):526-528. doi: 10.4103/0028-3886.227260.
4
Hybrid nanogels with unique designs for improved tumor theranostics.
Nanomedicine (Lond). 2020 Jun;15(15):1455-1458. doi: 10.2217/nnm-2020-0142. Epub 2020 Jun 9.
5
The ICPO Foundation-on the way toward collaborative growth of theranostics.
Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):443-444. doi: 10.1007/s00259-021-05651-2.
6
Nuclear medicine theranostics comes of age.
Lancet Oncol. 2021 Nov;22(11):1497-1498. doi: 10.1016/S1470-2045(21)00540-4.
7
Not All Gatekeepers Are Theranostics.
J Nucl Med. 2023 Oct;64(10):1662. doi: 10.2967/jnumed.123.266006. Epub 2023 Jun 29.
8
Reply to: Not All Gatekeepers Are Theranostics.
J Nucl Med. 2023 Oct;64(10):1662-1663. doi: 10.2967/jnumed.123.266028. Epub 2023 Jun 29.
9
Reply to "Theranostics Is Not Radiotheranostics".
J Nucl Med. 2023 Dec 1;64(12):2002. doi: 10.2967/jnumed.123.266491.
10
Theranostics Is Not Radiotheranostics.
J Nucl Med. 2023 Dec 1;64(12):2002. doi: 10.2967/jnumed.123.266292.
引用本文的文献
1
Molecular and modular intricacies of precision oncology.
Front Immunol. 2024 Oct 23;15:1476494. doi: 10.3389/fimmu.2024.1476494. eCollection 2024.
2
Recent Advances in Functionalized Nanoparticles in Cancer Theranostics.
Nanomaterials (Basel). 2022 Aug 17;12(16):2826. doi: 10.3390/nano12162826.
3
The Evolution of Targeted Radionuclide Diagnosis of HER2-Positive Breast Cancer.
Acta Naturae. 2022 Apr-Jun;14(2):4-15. doi: 10.32607/actanaturae.11611.
4
Pharmacotherapeutic Management of Well-Differentiated Neuroendocrine Tumors in Older Patients: Current Status and Potential Therapies.
Drugs Aging. 2022 Apr;39(4):257-269. doi: 10.1007/s40266-022-00934-1. Epub 2022 Mar 25.
5
Theranostic Advances in Breast Cancer in Nuclear Medicine.
Int J Mol Sci. 2021 Apr 27;22(9):4597. doi: 10.3390/ijms22094597.
6
Preclinical PET Imaging of NTSR-1-Positive Tumors with Cu- and Ga-DOTA-Neurotensin Analogs and Therapy with an Ac-DOTA-Neurotensin Analog.
Cancer Biother Radiopharm. 2021 Oct;36(8):651-661. doi: 10.1089/cbr.2020.3926. Epub 2020 Aug 19.
7
Siderophore-Based Molecular Imaging of Fungal and Bacterial Infections-Current Status and Future Perspectives.
J Fungi (Basel). 2020 May 29;6(2):73. doi: 10.3390/jof6020073.
Zotero 插件